Symposia & Breakout Sessions

(Please note this programme is subject to change)

4:45 PM - 5:30 PM (GMT) - Wednesday, February 26, 2025
Symposium
Unravelling the Pathways to Early Intervention in ATTR-CM

Chair: Julian Gillmore, London, UK

Faculty: Margot Davis, Vancouver, CA; Ahmad Masri, Portland, US

Overview

This interactive programme explores the critical steps in recognising and managing transthyretin amyloid cardiomyopathy (ATTR-CM) at an early stage. The expert faculty will share insights on current stabilising agents, examine disease progression trajectories and discuss emerging therapies. Gain practical insights into optimising patient outcomes through timely intervention and evolving management strategies.

Agenda

  • Welcome and Introduction – Julian Gillmore, London, UK
  • Case Study – Ahmad Masri, Portland, US
  • Managing Disease Early – Julian Gillmore, London, UK
  • ATTR Stabilisation: Current Standard of Care – Margot Davis, Vancouver, CA
  • What Are Our Future Options? Panel Discussion and Q&A – All

Learning Objectives

  • Review the binding affinity for current stabilising agents 
  • Recall the trajectory of disease progression in ATTR-CM 
  • Discuss future options for individuals who progress on treatment 

This symposium is supported by an unrestricted educational grant from Bayer.

*Unravelling the Pathways to Early Intervention in ATTR-CM has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.



Supporters

AstraZeneca and Bayer have provided a grant towards this independent project and have had no involvement in its creation or organisation.

If you’re interested in becoming a partner at NHA, please contact sales@radcliffe-group.com

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com